The MSKCC-Cornell Center for Translation of Cancer Nanomedicines (MC2TCN) will establish an environment for the enhanced integration of basic materials research on specific classes of ultrasmall (<10 nm diameter) nanoparticles with translational efforts in the field of oncology. In order to achieve this goal we propose a comprehensive Administration Core within the Center. This core will be the source of multidisciplinary Center leadership, and will manage the Center's administrative efforts to streamline the development of highly integrated novel particle architectures and geometries to improve intraoperative tools for cancer diagnosis and staging, as well as to enhance the efficacy of radiotherapeutic and drug delivery products. This will require the development and/or identification of new characterization methods, genetically engineered animal models, imaging analysis tools, and quantitative histological procedures. Our proposed leadership and management structure ensures that the Center's investigators and other researchers at Cornell, MSKCC, and University of Missouri will have access to infrastructure, personnel, and expertise that can be used to facilitate these necessary developments for translation of these nanoparticle products into the clinic and their subsequent commercialization. We have proposed a leadership and management structure that will bridge existing gaps between basic and clinical researchers, ensuring that all of the Center's investigators can take full advantage of both the existing and proposed inter-institutional resources for cancer nanotechnology applications. By accomplishing the Aims proposed in this section, the Administrative Core will provide leadership to the Center and will streamline administrative efforts to accelerate the development of clinically translatable nanoparticle products.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA199081-01
Application #
8961781
Study Section
Special Emphasis Panel (ZCA1-TCRB-Q (M1))
Project Start
2015-08-27
Project End
2020-07-31
Budget Start
2015-08-27
Budget End
2016-07-31
Support Year
1
Fiscal Year
2015
Total Cost
$157,876
Indirect Cost
$42,575
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
GrĂ¼ner, Florian; Blumendorf, Florian; Schmutzler, Oliver et al. (2018) Localising functionalised gold-nanoparticles in murine spinal cords by X-ray fluorescence imaging and background-reduction through spatial filtering for human-sized objects. Sci Rep 8:16561
Chen, Feng; Ma, Kai; Madajewski, Brian et al. (2018) Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer. Nat Commun 9:4141
Nath, Pooja; Mangal, Rahul; Kohle, Ferdinand et al. (2018) Dynamics of Nanoparticles in Entangled Polymer Solutions. Langmuir 34:241-249
Chen, Feng; Zhang, Xiuli; Ma, Kai et al. (2018) Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging. ACS Appl Mater Interfaces 10:4379-4393
Ma, Kai; Gong, Yunye; Aubert, Tangi et al. (2018) Self-assembly of highly symmetrical, ultrasmall inorganic cages directed by surfactant micelles. Nature 558:577-580
He, Frank; Chiou, Aaron E; Loh, Hyun Chae et al. (2017) Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis. Proc Natl Acad Sci U S A 114:10542-10547
Chen, Feng; Ma, Kai; Benezra, Miriam et al. (2017) Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property Correlations. Chem Mater 29:8766-8779
Chen, Feng; Ma, Kai; Zhang, Li et al. (2017) Target-or-Clear Zirconium-89 Labeled Silica Nanoparticles for Enhanced Cancer-Directed Uptake in Melanoma: A Comparison of Radiolabeling Strategies. Chem Mater 29:8269-8281
Yoo, B; Ma, K; Wiesner, U et al. (2017) Expanding Analytical Tools for Characterizing Ultrasmall Silica-based Nanoparticles. RSC Adv 7:16861-16865
Bradbury, Michelle S; Pauliah, Mohan; Zanzonico, Pat et al. (2016) Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8:535-53

Showing the most recent 10 out of 12 publications